Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Regulation of zebrafish melanocyte development by ligand-dependent BMP signaling.

Gramann AK, Venkatesan AM, Guerin M, Ceol CJ.

Elife. 2019 Dec 23;8. pii: e50047. doi: 10.7554/eLife.50047.

2.

Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis.

Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R 3rd, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH.

Brachytherapy. 2019 Nov 27. pii: S1538-4721(19)30588-4. doi: 10.1016/j.brachy.2019.09.010. [Epub ahead of print]

PMID:
31786169
3.

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer.

Expert Panel on Urologic Imaging, Allen BC, Oto A, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Lloyd S, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Vapiwala N, Venkatesan AM, Wang CL, Yoo DC, Lockhart ME.

J Am Coll Radiol. 2019 Nov;16(11S):S417-S427. doi: 10.1016/j.jacr.2019.05.026.

PMID:
31685109
4.

ACR Appropriateness Criteria® Penetrating Trauma-Lower Abdomen and Pelvis.

Expert Panel on Urological Imaging, Heller MT, Oto A, Allen BC, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Mackenzie DC, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME.

J Am Coll Radiol. 2019 Nov;16(11S):S392-S398. doi: 10.1016/j.jacr.2019.05.023.

PMID:
31685107
5.

ACR Appropriateness Criteria® Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia.

Expert Panel on Urological Imaging, Alexander LF, Oto A, Allen BC, Akin O, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Maranchie JK, Mody RN, Patel BN, Schieda N, Schuster DM, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME.

J Am Coll Radiol. 2019 Nov;16(11S):S378-S383. doi: 10.1016/j.jacr.2019.05.031.

PMID:
31685105
6.

MRI for Radiation Therapy Planning in Human Papillomavirus-associated Gynecologic Cancers.

Venkatesan AM, Menias CO, Jones KM, Rauch GM, Stafford RJ, Klopp AH.

Radiographics. 2019 Sep-Oct;39(5):1476-1500. doi: 10.1148/rg.2019180121.

PMID:
31498740
7.

ACR Appropriateness Criteria® Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass.

Expert Panel on Urological Imaging:, Wang CL, Aryal B, Oto A, Allen BC, Akin O, Alexander LF, Bardo DME, Chong J, Froemming AT, Fulgham PF, Heller MT, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME.

J Am Coll Radiol. 2019 May;16(5S):S38-S43. doi: 10.1016/j.jacr.2019.02.016.

PMID:
31054757
8.

Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis.

Campbell MT, Bilen MA, Shah AY, Lemke E, Jonasch E, Venkatesan AM, Altinmakas E, Duran C, Msaouel P, Tannir NM.

Eur J Cancer. 2018 Nov;104:188-194. doi: 10.1016/j.ejca.2018.08.014. Epub 2018 Oct 28.

PMID:
30380460
9.

Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology.

Chehab MA, Thakor AS, Tulin-Silver S, Connolly BL, Cahill AM, Ward TJ, Padia SA, Kohi MP, Midia M, Chaudry G, Gemmete JJ, Mitchell JW, Brody L, Crowley JJ, Heran MKS, Weinstein JL, Nikolic B, Dariushnia SR, Tam AL, Venkatesan AM.

J Vasc Interv Radiol. 2018 Nov;29(11):1483-1501.e2. doi: 10.1016/j.jvir.2018.06.007. Epub 2018 Sep 28. Review. No abstract available.

PMID:
30274857
10.

Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment.

Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1046-1056. doi: 10.1016/j.ijrobp.2018.03.028. Epub 2018 Mar 30. Review.

PMID:
30012524
11.

Conditional survival of patients with small renal masses undergoing active surveillance.

Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF.

BJU Int. 2019 Mar;123(3):447-455. doi: 10.1111/bju.14486. Epub 2018 Aug 27.

PMID:
30007044
12.

Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy.

Sanders JW, Song H, Frank SJ, Bathala T, Venkatesan AM, Anscher M, Tang C, Bruno TL, Wei W, Ma J.

Brachytherapy. 2018 Sep - Oct;17(5):816-824. doi: 10.1016/j.brachy.2018.05.003. Epub 2018 Jun 4.

PMID:
29880449
13.

ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder Cancer.

Expert Panel on Urologic Imaging:, van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME.

J Am Coll Radiol. 2018 May;15(5S):S150-S159. doi: 10.1016/j.jacr.2018.03.020.

PMID:
29724418
14.

ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.

Expert Panel on Urologic Imaging:, Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM.

J Am Coll Radiol. 2018 May;15(5S):S132-S149. doi: 10.1016/j.jacr.2018.03.019.

PMID:
29724417
15.

Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.

Jawed I, Velarde M, Därr R, Wolf KI, Adams K, Venkatesan AM, Balasubramaniam S, Poruchynsky MS, Reynolds JC, Pacak K, Fojo T.

Cell Mol Neurobiol. 2018 Jul;38(5):1099-1106. doi: 10.1007/s10571-018-0579-4. Epub 2018 Apr 5.

16.

Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.

Venkatesan AM, Vyas R, Gramann AK, Dresser K, Gujja S, Bhatnagar S, Chhangawala S, Gomes CBF, Xi HS, Lian CG, Houvras Y, Edwards YJK, Deng A, Green M, Ceol CJ.

J Clin Invest. 2018 Jan 2;128(1):294-308. doi: 10.1172/JCI92513. Epub 2017 Dec 4.

17.

Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate.

Sun CY, Walker CM, Michel KA, Venkatesan AM, Lai SY, Bankson JA.

Magn Reson Med. 2018 Jun;79(6):3239-3248. doi: 10.1002/mrm.26992. Epub 2017 Nov 1.

18.

Synthetic Study toward Total Synthesis of (±)-Germine: Synthesis of (±)-4-Methylenegermine.

Stork G, Yamashita A, Hanson RM, Phan L, Phillips E, Dubé D, Bos PH, Clark AJ, Gough M, Greenlee ML, Jiang Y, Jones K, Kitamura M, Leonard J, Liu T, Parsons PJ, Venkatesan AM.

Org Lett. 2017 Oct 6;19(19):5150-5153. doi: 10.1021/acs.orglett.7b02434. Epub 2017 Sep 6.

PMID:
28876074
19.

Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.

Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C.

JAMA Surg. 2017 Oct 18;152(10):e172986. doi: 10.1001/jamasurg.2017.2986. Epub 2017 Oct 18.

20.

Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.

Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence MG, Trivedi A, Henderson C, Hsu A, Quezado M, Kleiner DE, Venkatesan AM, Holland SM, Freeman AF, Heller T.

J Clin Immunol. 2017 Oct;37(7):695-700. doi: 10.1007/s10875-017-0429-z. Epub 2017 Aug 13.

PMID:
28803389
21.

ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging.

Expert Panel on Urologic Imaging:, Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC.

J Am Coll Radiol. 2017 May;14(5S):S245-S257. doi: 10.1016/j.jacr.2017.02.026. Review.

PMID:
28473080
22.

Prostate magnetic resonance imaging for brachytherapists: Anatomy and technique.

Venkatesan AM, Stafford RJ, Duran C, Soni PD, Berlin A, McLaughlin PW.

Brachytherapy. 2017 Jul - Aug;16(4):679-687. doi: 10.1016/j.brachy.2016.12.013. Epub 2017 Feb 23.

PMID:
28237429
23.

Prostate magnetic resonance imaging for brachytherapists: Diagnosis, imaging pitfalls, and post-therapy assessment.

Venkatesan AM, Stafford RJ, Duran C, Soni PD, Berlin A, McLaughlin PW.

Brachytherapy. 2017 Jul - Aug;16(4):688-697. doi: 10.1016/j.brachy.2016.12.012. Epub 2017 Jan 27. Review.

PMID:
28139419
24.

Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.

Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ.

Brachytherapy. 2017 Jul - Aug;16(4):743-753. doi: 10.1016/j.brachy.2016.11.014. Epub 2017 Jan 4.

25.

Magnetic resonance imaging-guided functional anatomy approach to prostate brachytherapy.

Soni PD, Berlin A, Venkatesan AM, McLaughlin PW.

Brachytherapy. 2017 Jul - Aug;16(4):698-714. doi: 10.1016/j.brachy.2016.11.009. Epub 2016 Dec 29.

PMID:
28040380
26.

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF.

J Hepatol. 2017 Mar;66(3):545-551. doi: 10.1016/j.jhep.2016.10.029. Epub 2016 Nov 2.

27.

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Payabyab EC, Balasubramaniam S, Edgerly M, Velarde M, Merino MJ, Venkatesan AM, Leuva H, Litman T, Bates SE, Fojo T.

Clin Cancer Res. 2016 Oct 15;22(20):4989-5000.

28.

Image fusion and navigation platforms for percutaneous image-guided interventions.

Rajagopal M, Venkatesan AM.

Abdom Radiol (NY). 2016 Apr;41(4):620-8. doi: 10.1007/s00261-016-0645-7. Review.

PMID:
26826086
29.

Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors.

Assadipour Y, Azoury SC, Schaub NN, Hong Y, Eil R, Inchauste SM, Steinberg SM, Venkatesan AM, Libutti SK, Hughes MS.

Am J Surg. 2016 Jul;212(1):40-6. doi: 10.1016/j.amjsurg.2015.07.031. Epub 2015 Dec 12.

PMID:
26782807
30.

Navigational Tools for Interventional Radiology and Interventional Oncology Applications.

Chehab MA, Brinjikji W, Copelan A, Venkatesan AM.

Semin Intervent Radiol. 2015 Dec;32(4):416-27. doi: 10.1055/s-0035-1564705. Review.

31.

High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.

Copelan A, Hartman J, Chehab M, Venkatesan AM.

Semin Intervent Radiol. 2015 Dec;32(4):398-415. doi: 10.1055/s-0035-1564793. Review.

32.

Vaginal Pessary for Uterine Repositioning during High-Intensity Focused Ultrasound Ablation of Uterine Leiomyomas.

Klepac Pulanic T, Venkatesan AM, Segars J, Sokka S, Wood BJ, Stratton P.

Gynecol Obstet Invest. 2016;81(3):285-8. doi: 10.1159/000441782. Epub 2015 Nov 20.

33.

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.

Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF.

United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587.

34.

Magnetic Resonance-Guided Drug Delivery.

Mikhail AS, Partanen A, Yarmolenko P, Venkatesan AM, Wood BJ.

Magn Reson Imaging Clin N Am. 2015 Nov;23(4):643-55. doi: 10.1016/j.mric.2015.05.012. Epub 2015 Jul 9. Review.

35.

Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).

Hughes MS, Azoury SC, Assadipour Y, Straughan DM, Trivedi AN, Lim RM, Joy G, Voellinger MT, Tang DM, Venkatesan AM, Chen CC, Louie A, Quezado MM, Forbes J, Wank SA.

Surgery. 2016 Jan;159(1):350-6. doi: 10.1016/j.surg.2015.05.041. Epub 2015 Oct 9.

36.

Clinical and Imaging Follow-up Practices after Transarterial Therapy for Primary and Secondary Hepatic Malignancies: Results of an Online Survey.

Gaba RC, Baerlocher MO, Nikolic B, Venkatesan AM, Lewandowski RJ.

Acad Radiol. 2015 Dec;22(12):1510-5. doi: 10.1016/j.acra.2015.08.016. Epub 2015 Oct 1.

PMID:
26432072
37.

Opportunities for Research, Education, and Training at the National Institutes of Health.

Venkatesan AM.

Semin Intervent Radiol. 2015 Sep;32(3):329-32. doi: 10.1055/s-0035-1556827. Review. No abstract available.

38.

A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.

Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA.

Gastroenterology. 2015 Jul;149(1):67-78. doi: 10.1053/j.gastro.2015.04.008. Epub 2015 Apr 9.

39.

Clinical experience with cone-beam CT navigation for tumor ablation.

Abi-Jaoudeh N, Venkatesan AM, Van der Sterren W, Radaelli A, Carelsen B, Wood BJ.

J Vasc Interv Radiol. 2015 Feb;26(2):214-9. doi: 10.1016/j.jvir.2014.10.049.

40.

Occupational radiation protection of pregnant or potentially pregnant workers in IR: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe.

Dauer LT, Miller DL, Schueler B, Silberzweig J, Balter S, Bartal G, Chambers C, Collins JD, Damilakis J, Dixon RG, Marx MV, Stecker MS, Vañó E, Venkatesan AM, Nikolic B; Society of Interventional Radiology Safety and Health Committee; Cardiovascular and Interventional Radiological Society of Europe Standards of Practice Committee.

J Vasc Interv Radiol. 2015 Feb;26(2):171-81. doi: 10.1016/j.jvir.2014.11.026. No abstract available.

PMID:
25645407
41.

The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.

O'Sullivan C, Edgerly M, Velarde M, Wilkerson J, Venkatesan AM, Pittaluga S, Yang SX, Nguyen D, Balasubramaniam S, Fojo T.

J Clin Endocrinol Metab. 2014 Apr;99(4):1291-7. doi: 10.1210/jc.2013-2298. Epub 2014 Jan 1.

42.

Accuracy and efficacy of percutaneous biopsy and ablation using robotic assistance under computed tomography guidance: a phantom study.

Koethe Y, Xu S, Velusamy G, Wood BJ, Venkatesan AM.

Eur Radiol. 2014 Mar;24(3):723-30. doi: 10.1007/s00330-013-3056-y. Epub 2013 Nov 13.

43.

PET-guided biopsy with needle navigation facilitates diagnosis of angiosarcoma in neurofibromatosis type 1.

Koethe Y, Widemann BC, Hajjar F, Wood BJ, Venkatesan AM.

Pediatr Blood Cancer. 2013 Dec;60(12):E166-9. doi: 10.1002/pbc.24668. Epub 2013 Aug 7.

44.

Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.

Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA.

BJU Int. 2013 Aug;112(4):508-16. doi: 10.1111/bju.12126. Epub 2013 Jun 7.

45.

Is magnetic resonance imaging sufficient to diagnose rudimentary uterine horn? A case report and review of the literature.

Devine K, McCluskey T, Henne M, Armstrong A, Venkatesan AM, Decherney A.

J Minim Invasive Gynecol. 2013 Jul-Aug;20(4):533-6. doi: 10.1016/j.jmig.2013.01.012. Epub 2013 Mar 25. Review.

46.

Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review.

Lewis EI, Chason RJ, DeCherney AH, Armstrong A, Elkas J, Venkatesan AM.

Fertil Steril. 2013 Jun;99(7):2017-24. doi: 10.1016/j.fertnstert.2013.01.147. Epub 2013 Mar 5. Review.

47.

Multimodality image fusion-guided procedures: technique, accuracy, and applications.

Abi-Jaoudeh N, Kruecker J, Kadoury S, Kobeiter H, Venkatesan AM, Levy E, Wood BJ.

Cardiovasc Intervent Radiol. 2012 Oct;35(5):986-98. Epub 2012 Aug 1. Review.

48.

Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.

Venkatesan AM, Partanen A, Pulanic TK, Dreher MR, Fischer J, Zurawin RK, Muthupillai R, Sokka S, Nieminen HJ, Sinaii N, Merino M, Wood BJ, Stratton P.

J Vasc Interv Radiol. 2012 Jun;23(6):786-794.e4. doi: 10.1016/j.jvir.2012.02.015.

49.

Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study.

Abi-Jaoudeh N, Mielekamp P, Noordhoek N, Venkatesan AM, Millo C, Radaelli A, Carelsen B, Wood BJ.

J Vasc Interv Radiol. 2012 Jun;23(6):737-43. doi: 10.1016/j.jvir.2012.02.006. Epub 2012 Apr 10.

50.

Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.

Urology. 2012 Jan;79(1):233-9. doi: 10.1016/j.urology.2011.10.002.

Supplemental Content

Loading ...
Support Center